Therefore, the demonstrated decrease in IL-6 levels could justify the significant reduction in the viability of the F3II tumor line treated with the venom compared to the untreated control, which constitutes an unprecedented study for scorpion venoms. The gene discussed is IL6; the disease is neoplasm.